Pacific Bio (PACB) Tops Q1 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $38.9 million versus the consensus estimate of $34.38 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Pacific Bio (PACB) Misses Q2 EPS by 1c
• Bimini Capital Management (BMNM) Tops Q2 EPS by 4c